Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09105 | 31872499 | Liver Int | Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitis. | 2020 | Details |
| A09106 | 31871925 | Can J Gastroenterol Hepatol | Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease according to Different Menstrual Status Groups. | 2019 | Details |
| A09107 | 31870950 | J Hepatol | Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. | 2019 | Details |
| A09108 | 31870938 | Peptides | Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction. | 2019 | Details |
| A09109 | 31870746 | Ann Hepatol | Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis. | 2019 | Details |
| A09110 | 31870745 | Ann Hepatol | Comparing hepatic steatosis distribution patterns between non-alcoholic fatty liver disease and fatty liver disease with chronic hepatitis B by second-harmonic generation/two-photon excited fluorescence method. | 2019 | Details |
| A09111 | 31870140 | Korean J Gastroenterol | Diagnostic Performance of Serum Asialo-α1-acid Glycoprotein for Advanced Liver Fibrosis or Cirrhosis in Patients with Chronic Hepatitis B or Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09112 | 31870134 | Korean J Intern Med | Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort study. | 2019 | Details |
| A09113 | 31870087 | Korean J Pediatr | Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity. | 2019 | Details |
| A09114 | 31869736 | Nucl Med Biol | Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis. | 2019 | Details |
| A09115 | 31868526 | Expert Opin Investig Drugs | Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A09116 | 31868169 | Med Sci Monit | Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study. | 2019 | Details |
| A09118 | 31867782 | J Gastroenterol Hepatol | When the liver gets stiff, the tough get moving. | 2020 | Details |
| A09119 | 31867441 | Hepatoma Res | Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma. | 2019 | Details |
| A09120 | 31867105 | Cancer Metab | SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia. | 2019 | Details |
| A09121 | 31867104 | J Anim Sci Biotechnol | Hepatic metabolomics and transcriptomics to study susceptibility to ketosis in response to prepartal nutritional management. | 2019 | Details |
| A09122 | 31867007 | Front Immunol | Macrophages in Zebrafish Models of Liver Diseases. | 2019 | Details |
| A09123 | 31866798 | Contrast Media Mol Imaging | Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH). | 2019 | Details |
| A09124 | 31866404 | Eur J Pharmacol | Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases. | 2019 | Details |
| A09125 | 31866269 | J Visc Surg | Metabolic syndrome and hepatic surgery. | 2019 | Details |
| A09126 | 31865799 | Hypertension | Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension. | 2019 | Details |
| A09127 | 31865317 | Dig Dis | Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. | 2019 | Details |
| A09128 | 31865143 | Biomed Pharmacother | Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. | 2019 | Details |
| A09129 | 31864032 | Environ Int | Transcriptome responses in blood reveal distinct biological pathways associated with arsenic exposure through drinking water in rural settings of Punjab, Pakistan. | 2019 | Details |
| A09130 | 31863731 | Exp Neurol | Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology? | 2019 | Details |
| A09131 | 31863408 | Obes Surg | Outcomes of Bariatric Surgery in Chronic Liver Disease: a National Inpatient Sample Analysis. | 2020 | Details |
| A09132 | 31862949 | Sci Rep | Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis. | 2019 | Details |
| A09133 | 31862937 | Sci Rep | Urinary Levels of Titin-N Fragment, a Skeletal Muscle Damage Marker, are Increased in Subjects with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09134 | 31862486 | J Hepatol | Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A09135 | 31861914 | Cells | Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts. | 2019 | Details |
| A09136 | 31861818 | Cells | Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. | 2019 | Details |
| A09137 | 31861664 | Int J Mol Sci | Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover. | 2019 | Details |
| A09138 | 31861591 | J Clin Med | Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy. | 2019 | Details |
| A09139 | 31861497 | Nutrients | Protective Effect of α-Linolenic Acid on Non-Alcoholic Hepatic Steatosis and Interleukin-6 and -10 in Wistar Rats. | 2019 | Details |
| A09142 | 31860170 | Cancer Med | Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A09143 | 31860081 | Biosci Rep | Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A09144 | 31859979 | Rev Med Chil | [Quantification of liver fat infiltration by magnetic resonance]. | 2019 | Details |
| A09146 | 31858523 | Histol Histopathol | Hepatocellular carcinoma in non-alcoholic fatty liver disease (NAFLD) - pathological evidence for a predominance of steatohepatitic inflammatory non-proliferative subtype. | 2019 | Details |
| A09147 | 31858390 | Endocrine | Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity. | 2019 | Details |
| A09148 | 31858105 | J Nutr | Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet. | 2020 | Details |
| A09150 | 31857389 | J Lipid Res | Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver. | 2019 | Details |
| A09151 | 31857195 | J Hepatol | ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation. | 2019 | Details |
| A09152 | 31857090 | Chem Biol Interact | Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity. | 2019 | Details |
| A09153 | 31856189 | PLoS One | Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy. | 2019 | Details |
| A09154 | 31854001 | Alcohol Clin Exp Res | Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies. | 2020 | Details |
| A09155 | 31853866 | Obes Surg | Bariatric Surgery in Cirrhotic Patients: Is It Safe? | 2020 | Details |
| A09156 | 31853615 | Naunyn Schmiedebergs Arch Pharmacol | Adelmidrol protects against non-alcoholic steatohepatitis in mice. | 2019 | Details |
| A09157 | 31852748 | J Investig Med | Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy. | 2019 | Details |
| A09158 | 31852647 | Nan Fang Yi Ke Da Xue Xue Bao | [Predictive value of body mass index combined with waist circumference for new-onset nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus]. | 2019 | Details |
| A09159 | 31852635 | Lancet Gastroenterol Hepatol | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. | 2019 | Details |
| A09161 | 31852444 | BMC Gastroenterol | Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. | 2019 | Details |
| A09163 | 31852298 | Artif Cells Nanomed Biotechnol | Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease. | 2020 | Details |
| A09164 | 31852081 | Medicine (Baltimore) | Nonalcoholic steatohepatitis: A scientometric analysis of publications during 1980-2018. | 2019 | Details |
| A09165 | 31851849 | Scand J Clin Lab Invest | Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study). | 2019 | Details |
| A09166 | 31850710 | Clin Lab | MiR-218-XOR-ROS Pathway Regulates the Progression of Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09171 | 31850288 | Front Pediatr | Metabolic Syndrome Is Associated With Advanced Liver Fibrosis Among Pediatric Patients With Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09172 | 31849997 | Front Immunol | Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases. | 2019 | Details |
| A09174 | 31849065 | J Sci Food Agric | The effects of hydroalcoholic extract of spinach on prevention and treatment of some metabolic and histologic features in a rat model of nonalcoholic fatty liver disease. | 2020 | Details |
| A09175 | 31847612 | Expert Opin Investig Drugs | The molecular basis for current targets of NASH therapies. | 2019 | Details |
| A09176 | 31847199 | Nutrients | Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? | 2019 | Details |
| A09177 | 31847187 | J Clin Med | Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09178 | 31847157 | Nutrients | Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice. | 2019 | Details |
| A09179 | 31846961 | Lifestyle Genom | One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. | 2019 | Details |
| A09180 | 31846507 | Swiss Med Wkly | Nonalcoholic fatty liver disease burden - Switzerland 2018-2030. | 2019 | Details |
| A09181 | 31846425 | J Pediatr Endocrinol Metab | Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity. | 2020 | Details |
| A09182 | 31846369 | Am J Physiol Endocrinol Metab | Pgc1a is responsible for the sex differences in hepatic Cidec/Fsp27β mRNA expression in hepatic steatosis of mice fed a Western diet. | 2019 | Details |
| A09183 | 31845776 | Am Fam Physician | Cirrhosis: Diagnosis and Management. | 2019 | Details |
| A09184 | 31845054 | J Gastroenterol | Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. | 2019 | Details |
| A09185 | 31843596 | Clin Gastroenterol Hepatol | Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard. | 2019 | Details |
| A09186 | 31843573 | J Ethnopharmacol | San-Huang-Tang protects obesity/diabetes induced NAFLD by upregulating PGC-1α/PEPCK signaling in obese and galr1 knockout mice models. | 2019 | Details |
| A09187 | 31843499 | Am J Pathol | Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2. | 2019 | Details |
| A09189 | 31842467 | Int J Mol Sci | Resveratrol Treatment Enhances the Cellular Response to Leptin by Increasing OBRb Content in Palmitate-Induced Steatotic HepG2 Cells. | 2019 | Details |
| A09190 | 31841744 | Nutr Res | An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial. | 2019 | Details |
| A09191 | 31841118 | Aging (Albany NY) | Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress. | 2019 | Details |
| A09192 | 31840883 | Phytother Res | Protective effects of glycycoumarin on liver diseases. | 2019 | Details |
| A09193 | 31840865 | Nutr Clin Pract | Evolution of NAFLD and Its Management. | 2019 | Details |
| A09194 | 31840531 | Clin Appl Thromb Hemost | Nonalcoholic Fatty Liver Disease and Thrombocytopenia III: Its Association With Insulin Resistance. | 2020 | Details |
| A09195 | 31840358 | Hepatol Res | Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives. | 2020 | Details |
| A09196 | 31839747 | Int J Med Sci | PPAR δ inhibition protects against palmitic acid-LPS induced lipidosis and injury in cultured hepatocyte L02 cell. | 2019 | Details |
| A09197 | 31839486 | Cell Metab | Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09198 | 31838461 | Nutrition | Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features. | 2019 | Details |
| A09199 | 31838198 | Prostaglandins Other Lipid Mediat | Cd36 gene expression in adipose and hepatic tissue mediates the lipids accumulation in liver of obese rats with sucrose-induced hepatic steatosis. | 2019 | Details |
| A09200 | 31838177 | Int J Biochem Cell Biol | Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway. | 2019 | Details |
| A09201 | 31838076 | Gastroenterology | Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice. | 2019 | Details |
| A09202 | 31838050 | Chem Biol Interact | Stearoyl-CoA desaturase and tumorigenesis. | 2019 | Details |
| A09203 | 31837337 | Life Sci | Prefrontal cortex inflammation and liver pathologies accompany cognitive and motor deficits following Western diet consumption in non-obese female mice. | 2019 | Details |
| A09205 | 31836136 | Curr Probl Cancer | Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma. | 2019 | Details |
| A09206 | 31836013 | BMC Complement Altern Med | Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice. | 2019 | Details |
| A09207 | 31835505 | Nutrients | Weight Gain and De Novo Metabolic Disorders after Liver Transplantation. | 2019 | Details |
| A09208 | 31835362 | J Clin Med | Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09209 | 31835352 | Cells | The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases. | 2019 | Details |
| A09210 | 31835339 | Metabolites | Acupuncture on ST36, CV4 and KI1 Suppresses the Progression of Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. | 2019 | Details |
| A09212 | 31834842 | J Med Food | Effects of Eriobotrya japonica Water Extract on Alcoholic and Nonalcoholic Fatty Liver Impairment. | 2019 | Details |
| A09213 | 31834465 | Naunyn Schmiedebergs Arch Pharmacol | NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway. | 2019 | Details |
| A09214 | 31834057 | Eur J Gastroenterol Hepatol | Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter. | 2020 | Details |
| A09215 | 31833859 | Am J Gastroenterol | Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients. | 2020 | Details |
| A09216 | 31833787 | Epigenomics | Rat liver epigenome programing by perinatal exposure to 2,2',4'4'-tetrabromodiphenyl ether. | 2019 | Details |
| A09217 | 31832925 | Biol Trace Elem Res | Effect of Zn Supplementation on Trace Element Status in Rats with Diet-Induced Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09218 | 31832576 | Hepatol Commun | Insulin Resistance and Genetic Risk Predict Liver-Related Outcomes and Death in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09219 | 31832569 | Hepatol Commun | Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis. | 2019 | Details |